Ra Capital Management, L.P. Aclaris Therapeutics, Inc. Call Options Transaction History
Ra Capital Management, L.P.
- $6.17 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACRS
# of Institutions
99Shares Held
80.7MCall Options Held
257KPut Options Held
92.3K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$33.2 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$22.4 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$20.7 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$14.5 Million0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$10.1 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $155M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...